I. Williams

发表

Relationship between inflammatory and coagulation biomarkers and cardiac autonomic function in HIV-infected

J. Lundgren, P. Mollie, G. Grandits, 2014 .

Relationship between inflammatory and coagulation biomarkers and cardiac autonomic function in HIV-infected individuals.

E. Soliman, J. Lundgren, M. Roediger, 2014, Biomarkers in medicine.

Patient satisfaction with HIV service provision in NPMS hospitals: the development of a standard satisfaction questionnaire. NPMS Steering Group.

J. Carrier, E. Beck, I. Williams, 1999, AIDS care.

Persistence of HIV-1 Transmitted Drug Resistance Mutations

D. Webster, D. Pillay, Mark Hopkins, 2013, The Journal of infectious diseases.

Like a prayer: the role of spirituality and religion for people living with HIV in the UK.

I. Williams, J. Elford, D. Ridge, 2007, Sociology of health & illness.

Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia

C. Boshoff, D. Cornforth, A. Copas, 2004, AIDS.

Associations between plasma nucleoside reverse transcriptase inhibitors concentrations and cognitive function in people with HIV

A. Winston, C. Sabin, S. Khoo, 2021, PloS one.

Special Issue: British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (2013 update)

C. Leen, A. Winston, C. Sabin, 2014 .

British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV‐seropositive individuals 2011

B. Gazzard, N. Beeching, M. Singer, 2011, HIV medicine.

A tale of two countries: all‐cause mortality among people living with HIV and receiving combination antiretroviral therapy in the UK and Canada

B. Gazzard, C. Leen, B. Yip, 2017, HIV medicine.

Lower Healthcare Costs Associated with the Use of a Single-Pill ARV Regimen in the UK, 2004–2008

B. Gazzard, R. Brettle, M. Youle, 2012, PloS one.

Cost-Effectiveness of Early Treatment with First-Line NNRTI-Based HAART Regimens in the UK, 1996-2006

B. Gazzard, R. Brettle, M. Youle, 2011, PloS one.

The Cost-Effectiveness of Early Access to HIV Services and Starting cART in the UK 1996–2008

B. Gazzard, R. Brettle, M. Youle, 2011, PloS one.

Respiratory symptoms and chronic bronchitis in people with and without HIV infection

A. Winston, C. Sabin, F. Post, 2020, HIV medicine.

Cognitive function, depressive symptoms and syphilis in HIV-positive and HIV-negative individuals

A. Winston, C. Sabin, A. Milinkovic, 2019, International journal of STD & AIDS.

The dynamics of appearance and disappearance of HIV-1 integrase mutations during and after withdrawal of raltegravir therapy

D. Pillay, I. Williams, R. B. Ferns, 2009, AIDS.

Attenuated humoral responses in HIV infection after SARS-CoV-2 vaccination are linked to global B cell defects and cellular immune profiles

R. Gilson, M. Youle, C. Pinder, 2022, bioRxiv.

British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2015

C. Leen, A. Winston, C. Sabin, 2016, HIV medicine.

British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.)

C. Leen, A. Winston, C. Sabin, 2014, HIV medicine.

7.0 Managing virological failure

C. Leen, A. Winston, C. Sabin, 2012, HIV medicine.

Pain in people living with HIV and its association with healthcare resource use, well being and functional status

A. Winston, C. Sabin, M. Johnson, 2018, AIDS.

Defining cognitive impairment in people-living-with-HIV: the POPPY study

A. Winston, C. Sabin, J. Underwood, 2016, BMC Infectious Diseases.

Evolving controversies and challenges in the management of opportunistic infections in HIV-seropositive individuals.

I. Williams, D. Dockrell, M. Fisher, 2011, The Journal of infection.

6 Herpes viruses

C. Leen, I. Williams, S. Barton, 2011 .

Interruption of Antiretroviral Therapy and Risk of Cardiovascular Disease in Persons with HIV-1 Infection: Exploratory Analyses from the SMART Trial

A. Phillips, F. Goebel, J. Lundgren, 2008, Antiviral therapy.

Incomplete Reversibility of Estimated Glomerular Filtration Rate Decline Following Tenofovir Disoproxil Fumarate Exposure

C. Leen, D. Pillay, R. Gilson, 2014, The Journal of infectious diseases.

Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIV

B. Gazzard, C. Leen, C. Fraser, 2019, Journal of virus eradication.

Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial

A. Winston, M. Johnson, M. Gompels, 2015, The lancet. HIV.

British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapy

B. Gazzard, C. Leen, D. Pillay, 2001, HIV medicine.

Kaposi's Sarcoma-Associated Herpesvirus Cytotoxic T Lymphocytes Recognize and Target Darwinian Positively Selected Autologous K1 Epitopes

S. Henderson, C. Boshoff, M. Youle, 2003, Journal of Virology.

Recent trends and patterns in HIV‐1 transmitted drug resistance in the United Kingdom

C. Fraser, D. Pillay, C. Sabin, 2016, HIV medicine.

British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals

R. Brettle, J. Weber, I. Williams, 1997, The Lancet.

Autologous K 1 Epitopes Target Darwinian Positively Selected Cytotoxic T Lymphocytes Recognize and Kaposi ' s Sarcoma-Associated Herpesvirus

S. Henderson, C. Boshoff, M. Youle, 2003 .

Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic Reconstruction

C. Fraser, E. Volz, D. Pillay, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom

John P. Walsh, Andrew N. Phillips, Steve Kaye, 2007, AIDS.

Long-term follow-up of antiretroviral-naive HIV-positive patients treated with nevirapine.

C. Sabin, P. Easterbrook, I. Williams, 2001, Journal of acquired immune deficiency syndromes.

Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study

D. Pillay, C. Sabin, A. Phillips, 2012, BMJ : British Medical Journal.

Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study

C. Leen, D. Pillay, R. Gilson, 2017, The lancet. HIV.

Quality of life assessment among HIV‐positive persons entering the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

I. Williams, P. Pulik, MJ Wolff, 2015, HIV medicine.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Factors associated with obesity in the Pharmacokinetic and Clinical Observations in People over Fifty (POPPY) cohort: an observational cross‐sectional analysis

A. Winston, C. Sabin, D. De Francesco, 2020, HIV medicine.

Factors associated with obesity in the POPPY Cohort: an observational cross-sectional analysis

A. Winston, J. Anderson, I. Williams, 2020 .

Cohort profile: The Pharmacokinetic and clinical Observations in PeoPle over fiftY (POPPY) study.

A. Winston, C. Sabin, M. Johnson, 2018, International journal of epidemiology.

Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice

B. Gazzard, D. Pillay, C. Sabin, 2005, AIDS.

Factors Associated with D-Dimer Levels in HIV-Infected Individuals

Andrew N. Phillips, Ian Williams, Jens D. Lundgren, 2014, PloS one.

Development and application of a new measure of engagement in out‐patient HIV care

B. Gazzard, C. Leen, D. Pillay, 2016, HIV medicine.

Early and Prolonged Antiretroviral Therapy Is Associated with an HIV-1-Specific T-Cell Profile Comparable to That of Long-Term Non-Progressors

Sabine Yerly, Ian Williams, Jonathan Ainsworth, 2011, PloS one.

Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial.

J. Lundgren, J. Neaton, B. Grund, 2018, The lancet. HIV.

The Use and Cost of HIV Service Provision in England in 1996

P. Easterbrook, E. Beck, I. Williams, 1998, PharmacoEconomics.

Positive prevention: contemporary issues facing HIV positive people negotiating sex in the UK.

S. Ziebland, I. Williams, J. Elford, 2007, Social science & medicine.

The predictors of pain extent in people living with HIV.

A. Winston, C. Sabin, M. Johnson, 2020, AIDS.

Factors associated with virological rebound in HIV-infected patients receiving protease inhibitor monotherapy

N. Beeching, M. Johnson, K. Sanders, 2016, AIDS.

Evaluation of Cerebrospinal Fluid Virological Escape in Patients on Long-Term Protease Inhibitor Monotherapy

N. Beeching, A. Clarke, I. Williams, 2017, Antiviral therapy.

TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individuals

B. Clotet, C. Katlama, A. Phillips, 2008, AIDS.

Risk factors and impact of patterns of co-occurring comorbidities in people living with HIV.

A. Winston, C. Sabin, M. Johnson, 2019, AIDS.

Level of agreement between frequently used cardiovascular risk calculators in people living with HIV

A. Winston, C. Sabin, M. Youle, 2019, HIV medicine.

Treatment Outcome and Cost-Effectiveness of Different Highly Active Antiretroviral Therapy Regimens in the Uk (1996–2002)

B. Gazzard, R. Brettle, M. Youle, 2008, International Journal of STD and AIDS.

Associations between cognitive impairment and patient‐reported measures of physical/mental functioning in older people living with HIV

A. Winston, C. Sabin, J. Underwood, 2017, HIV medicine.

Changes in multimorbidity burden over a 3–5 year period among people with HIV

A. Winston, C. Sabin, D. De Francesco, 2023, Frontiers in Systems Biology.

Decreased morbidity and use of hospital services in English HIV-infected individuals with increased uptake of anti-retroviral therapy 1996-1997. National Prospective Monitoring System Steering Group.

P. Easterbrook, R. Newson, A. Molesworth, 1999, AIDS.

Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation

B. Gazzard, D. Webster, C. Leen, 2015, HIV medicine.

Host and disease factors are associated with cognitive function in European HIV‐infected adults prior to initiation of antiretroviral therapy

H. Amièva, A. Winston, A. Antinori, 2016, HIV medicine.

Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor.

D. Pillay, I. Williams, Linda J Harrison, 2012, The Journal of antimicrobial chemotherapy.

Intracellular and Plasma Pharmacokinetics of Nelfinavir and M8 in HIV-Infected Patients: Relationship with P-Glycoprotein Expression

D. Cornforth, M. Johnson, S. Khoo, 2004, Antiviral therapy.

Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance

C. Leen, C. Fraser, E. Volz, 2018, The Journal of antimicrobial chemotherapy.

High‐risk behaviours, and their associations with mental health, adherence to antiretroviral therapy and HIV parameters, in HIV‐positive men who have sex with men

A. Winston, C. Sabin, F. Post, 2018, HIV Medicine.

Depression, lifestyle factors and cognitive function in people living with HIV and comparable HIV‐negative controls

A. Winston, C. Sabin, J. Underwood, 2019, HIV medicine.

Polypharmacy and Drug–drug Interactions in Older and Younger People Living with HIV: The POPPY Study

A. Winston, C. Sabin, F. Post, 2019, Antiviral therapy.

Early virological response to HIV treatment: can we predict who is likely to experience subsequent treatment failure? Results from an observational cohort study, London, UK

A. Copas, A. Phillips, F. Lampe, 2017, Journal of the International AIDS Society.

Early virological response to HIV treatment: can we predict who is likely to experience subsequent treatment failure? Results from an observational cohort study, London, UK

A. Copas, A. Phillips, F. Lampe, 2017, Journal of the International AIDS Society.

Plasma NRTI concentration and their associations with liver and renal parameters in people living with HIV.

A. Winston, C. Sabin, S. Khoo, 2020, AIDS (London).

Rising Population Cost for Treating People Living with HIV in the UK, 1997-2013

B. Gazzard, R. Brettle, M. Youle, 2010, PloS one.

Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study

B. Gazzard, D. Webster, C. Leen, 2013, The Journal of antimicrobial chemotherapy.

Comorbidity indices in people with HIV and considerations for coronavirus disease 2019 outcomes

A. Winston, C. Sabin, D. De Francesco, 2020, AIDS.

Anticholinergic medications associated with falls and frailty in people with HIV

A. Winston, C. Sabin, F. Post, 2023, HIV medicine.

Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV‐positive persons version 9.0

S. McCormack, A. Mocroft, O. Kirk, 2018, HIV medicine.

Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study

D. Pillay, C. Sabin, A. Phillips, 2012, BMJ : British Medical Journal.

Host and disease factors are associated with cognitive function in European HIV‐infected adults prior to initiation of antiretroviral therapy

F. Raffi, I. Williams, A. Arenas-Pinto, 2016, HIV medicine.

Polypharmacy and Drug–drug Interactions in Older and Younger People Living with HIV: The POPPY Study

A. Winston, C. Sabin, F. Post, 2019, Antiviral therapy.

British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.)

C. Leen, A. Winston, C. Sabin, 2014, HIV medicine.

Measurement of Retinal Vessels as a Biomarker of Cerebrovascular Aging in Older HIV-Positive Men Compared With Controls

L. Haddow, R. Gilson, A. Winston, 2017, Journal of acquired immune deficiency syndromes.

Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV‐1 resistance mutation

Andrew L. Kerr, C. Leen, C. Fraser, 2020, HIV medicine.

Factors associated with virological rebound in HIV-infected patients receiving protease inhibitor monotherapy

N. Beeching, M. Johnson, A. Clarke, 2016, AIDS.

HIV testing in the UK

J. Friedland, I. Williams, E. Ong, 2009, The Lancet.